Skip to main content

Models of patient engagement for Alzheimer’s disease


Start Date
End Date
Total Funding
€ 4 591 968
Funding Programme
European Countries Involved

Dementia researchers are increasingly focusing their efforts on finding ways to prevent the onset of dementia symptoms in the first place, and for this they need to work with people who are still in the very earliest stages of the disease. The MOPEAD project aims to identify and test different models for engaging with this important group and determine which models work best in different situations. As well as adding to our understanding of the earliest stages of dementia, the project will facilitate recruitment for clinical trials and, most importantly, ensure that patients are able to access support from early on in their disease.

Project partners

Fundacio Ace
Eli Lilly And Company Limited
Asdm Consulting
Astrazeneca Ab
European Institute Of Women'S Health Company Limited By Guarantee
Gmv Soluciones Globales Internet Sau
Karolinska Institutet
Kite Innovation (Europe)
Spomincica Alzheimer Slovenija Slovensko Zdruzenje Za Pomoc Pri Demenci
Klinikum Der Universitaet Zu Koeln
Univerzitetni Klinicni
Center Ljubljana
Fundacio Hospital Universitari Vall D'Hebron - Institut De Recerca tichting Vumc
Alzheimer Europe
Modus Research And Innovation Limited

Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).